Blockade of 146b‑5p promotes inflammation in atherosclerosis‑associated foam cell formation by targeting TRAF6

  • Authors:
    • Nan Lin
    • Yi An
  • View Affiliations

  • Published online on: September 18, 2017     https://doi.org/10.3892/etm.2017.5121
  • Pages: 5087-5092
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Atherosclerosis (AS) is a chronic inflammation in response to lipid accumulation. Increasing evidence has demonstrated that numerous microRNAs (miRs) have critical roles in inflammatory responses. A previous study suggested that miR‑146b‑5p is possibly associated with AS; however, its exact role has remained largely elusive. The present study aimed to investigate the potential role of miR‑146b‑5p in AS and to explore the underlying mechanism. Fist, the levels of miR‑146b‑5p were determined in foam cells and clinical specimens from patients with AS by reverse‑transcription quantitative PCR. The role of miR‑146b‑5p in AS was then investigated by using miR‑146b‑5p inhibitor. The results demonstrated that the expression levels of miR‑146b‑5p were elevated in the lesions of patients with AS. In addition, the levels of miR‑146b‑5p in THP‑1 cells stimulated with phorbol 12‑myristate 13‑acetate (100 nM) to induce their differentiation into macrophages were dose‑ and time‑dependently elevated by oxidized low‑density lipoprotein treatment applied for inducing foam cell formation. miR‑146b‑5p was also revealed to directly target tumor necrosis factor receptor‑associated factor 6 (TRAF6), which functions as a signal transducer in the nuclear factor‑κB (NF‑κB) pathway. Furthermore, the present study reported for the first time that miR‑146b‑5p inhibition promotes the inflammatory response and enhances lipid uptake during foam cell formation. In conclusion, miR‑146b‑5p inhibition promoted chronic inflammation and had a detrimental role during AS‑associated foam cell formation by targeting TRAF6.
View Figures
View References

Related Articles

Journal Cover

November-2017
Volume 14 Issue 5

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Lin N and Lin N: Blockade of 146b‑5p promotes inflammation in atherosclerosis‑associated foam cell formation by targeting TRAF6. Exp Ther Med 14: 5087-5092, 2017
APA
Lin, N., & Lin, N. (2017). Blockade of 146b‑5p promotes inflammation in atherosclerosis‑associated foam cell formation by targeting TRAF6. Experimental and Therapeutic Medicine, 14, 5087-5092. https://doi.org/10.3892/etm.2017.5121
MLA
Lin, N., An, Y."Blockade of 146b‑5p promotes inflammation in atherosclerosis‑associated foam cell formation by targeting TRAF6". Experimental and Therapeutic Medicine 14.5 (2017): 5087-5092.
Chicago
Lin, N., An, Y."Blockade of 146b‑5p promotes inflammation in atherosclerosis‑associated foam cell formation by targeting TRAF6". Experimental and Therapeutic Medicine 14, no. 5 (2017): 5087-5092. https://doi.org/10.3892/etm.2017.5121